Clinical Study
Mean 5-Year Clinical and Radiographic Outcomes of Cementless Total Hip Arthroplasty in Patients under the Age of 30
Table 1
Patient demographics, perioperative data, and component data.
| Demographics | |
| Age at surgery [mean (range)] | 22 (15–29) | Gender | 24 F (60%) | 16 M (40%) | BMI [mean (range)] | 27 (19–43) | Side | 19 L (47.5%) | 21 R (52.5%) | Prior-hip surgery | 20 (50%) | Charnley class A | 21 (52.5%) | Charnley class B | 10 (25%) | Charnley class C | 9 (22.5%) |
| Diagnosis | |
| OA secondary to pediatric hip diseases | 21 (52.5%) | Avascular necrosis (AVN) | 12 (30%) | Inflammatory arthritis | 3 (7.5%) | Failed hip fusion | 2 (5%) | Septic arthritis | 1 (2.5%) | Posttraumatic arthritis | 1 (2.5%) |
| Perioperative data | |
| Estimated blood loss [mean (95% CI)] | 456 (374–537) | Postoperative transfusions | 6 (15%) | Intraoperative fractures | 2 (5%) | Posterior approach | 30 (75%) | Anterolateral approach | 8 (20%) | Direct lateral approach | 2 (5%) |
| Femoral component | |
| Modular cementless stem | 17 (42.5%) | Nonmodular cementless stem | 23 (57.5%) |
| Acetabular component | |
| Monoblock CoCr Cup | 21 (52.5%) | Titanium cup with coCr insert | 6 (15%) | Titanium cup with polyethylene insert | 13 (32.5%) |
| Articulation | |
| Metal-on-metal | 27 (67.5%) | Metal-on-conventional polyethylene | 11 (27.5%) | Metal-on-highly cross-linked polyethylene | 1 (2.5%) | Metal-on-vitamin E cross-linked polyethylene | 1 (2.5%) |
| Femoral head size | |
| 22 mm to 28 mm | 14 (35%) | 32 mm to 38 mm | 12 (30%) | 40 mm to 56 mm | 14 (35%) |
|
|